Times are tough for Auger Biotech. Having raised $85 million in an initial public offering of its stock early in the year, the company is poised to launch its product. If Auger engages in a promotional cam- paign costing $60 million this year, its annual after-tax cash flow over the next five years will be only $700,000. If it does not undertake the campaign, it expects its after-tax cash flow to be minus $18 million an- nually for the same period. Assuming the company has decided to stay in its chosen business, is this campaign worthwhile when the discount rate is 10 percent? Why or why not?

AppendixLO1